Literature DB >> 31152812

Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.

Xiang-Hua Yu1, Hao-Fan Wang1, Jing-Biao Wu1, Sha-Sha Wang1, Ya-Jie Tang2, Ya-Ling Tang3, Xin-Hua Liang4.   

Abstract

Non-coding RNAs (NcRNAs), a family of functional RNA molecules that cannot translate into proteins but control specific gene expression programs, have been shown to be implicated in various biological processes, including fatty acid metabolism. Fast-growing tumor cells rewire their fatty acid metabolic circuitry in order to meet the needs of energy storage, membrane proliferation, and the generation of signaling molecules, which is achieved by regulating a variety of key enzymes along with related signaling pathways in fatty acid metabolism. This review presents an update of our knowledge about the regulatory network of ncRNAs-specifically, microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs)-in this metabolic shift and discusses the possibility of ncRNA-based therapeutics being applied to the restoration of cancer-related fatty acid metabolism.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer fatty acid metabolism; Cancer therapy; De novo synthesis; Metastasis; Non-coding RNA

Mesh:

Substances:

Year:  2019        PMID: 31152812     DOI: 10.1016/j.lfs.2019.05.065

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer.

Authors:  Shasha Zhou; Zhiyuan Guo; Xueli Lv; Xueqiang Zhang
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

Review 2.  Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.

Authors:  Xinzhi Miao; Fang Wang; Tianyun Wang; Siti Razila Abdul Razak; Muhammad Amir Yunus; Ida Shazrina Ismail
Journal:  3 Biotech       Date:  2021-09-01       Impact factor: 2.893

3.  Long noncoding RNA HAS2-AS1 accelerates non-small cell lung cancer chemotherapy resistance by targeting LSD1/EphB3 pathway.

Authors:  Peng Sun; Limin Sun; Jia Cui; Lili Liu; Qing He
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 4.  Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer.

Authors:  Jingjing Huang; Jin Wang; Hua He; Zichen Huang; Sufang Wu; Chao Chen; Wenbing Liu; Li Xie; Yongguang Tao; Li Cong; Yiqun Jiang
Journal:  Int J Biol Sci       Date:  2021-10-25       Impact factor: 6.580

5.  Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma.

Authors:  Tianhao Sun; Dongning Liu; Jun Wu; William W Lu; Xiaoli Zhao; Tak Man Wong; Zhi-Li Liu
Journal:  Open Med (Wars)       Date:  2022-03-07

6.  The landscape of circular RNA in preterm birth.

Authors:  Yuxin Ran; Ruixin Chen; Dongni Huang; Yan Qin; Zheng Liu; Jie He; Youwen Mei; Yunqian Zhou; Nanlin Yin; Hongbo Qi
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

7.  MicroRNA-mediated regulation of lipid metabolism in virus-infected Emiliania huxleyi.

Authors:  Enquan Zhang; Jingjing Gao; Zehua Wei; Jun Zeng; Jian Li; Guiling Li; Jingwen Liu
Journal:  ISME J       Date:  2022-07-22       Impact factor: 11.217

Review 8.  Non-Coding RNAs Operate in the Crosstalk Between Cancer Metabolic Reprogramming and Metastasis.

Authors:  Ziyi Li; Xueying Sun
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

9.  Comprehensive analysis of competitive endogenous RNA network in colorectal cancer.

Authors:  Meng-Yi Zhang; Bin-Han Guo
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.